KD Logo

Keeping an Eye on SpringWorks Therapeutics Inc (SWTX) After Insider Trading Activity

SpringWorks Therapeutics Inc’s recent filing unveils that its Officer Saqib Islam acquired Company’s shares for reported $7.3 million on Feb 10 ’25. In the deal valued at $53.30 per share,137,000 shares were bought.

Then, DANIEL LYNCH bought 175,000 shares, generating $7,049,000 in total proceeds.

Before that, Daniel Pichl bought 29,750 shares. SpringWorks Therapeutics Inc shares valued at $1,617,329 were divested by the Officer at a price of $54.36 per share.

Evercore ISI initiated its SpringWorks Therapeutics Inc [SWTX] rating to an Outperform in a research note published on November 20, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. BofA Securities began covering SWTX with “Buy” recommendation on December 01, 2022. H.C. Wainwright maintained its rating on January 19, 2021. It rated SWTX as “a Buy”.

Price Performance Review of SWTX

On Tuesday, SpringWorks Therapeutics Inc [NASDAQ:SWTX] saw its stock jump 2.09% to $55.13. Over the last five days, the stock has gained 43.57%. SpringWorks Therapeutics Inc shares have risen nearly 52.59% since the year began. Nevertheless, the stocks have risen 18.74% over the past one year. While a 52-week high of $60.00 was reached on 02/10/25, a 52-week low of $28.21 was recorded on 01/15/25. SMA at 50 days reached $38.75, while 200 days put it at $37.65.

Levels Of Support And Resistance For SWTX Stock

The 24-hour chart illustrates a support level at 51.75, which if violated will result in even more drops to 48.38. On the upside, there is a resistance level at 57.56. A further resistance level may holdings at 60.00. The Relative Strength Index (RSI) on the 14-day chart is 77.44, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 9.86, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 19.04%. Stochastics %K at 79.31% indicates the stock is a holding.

How much short interest is there in SpringWorks Therapeutics Inc?

A steep rise in short interest was recorded in SpringWorks Therapeutics Inc stocks on 2025-01-31, growing by 2.13 million shares to a total of 14.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 12.27 million shares. There was a rise of 14.82%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on October 29, 2020 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $73.

Most Popular